Zealand Pharma A (NASDAQ: ZEAL) is owned by 1.84% institutional shareholders, 0.00% Zealand Pharma A insiders, and 98.16% retail investors. Goldman Sachs Group Inc is the largest individual Zealand Pharma A shareholder, owning 500,916.00 shares representing 1.15% of the company. Goldman Sachs Group Inc's Zealand Pharma A shares are currently valued at $8.34M.
If you're new to stock investing, here's how to buy Zealand Pharma A stock.